Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bio-Rad Laboratories
(NY:
BIO
)
280.25
-3.63 (-1.28%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
306,566
Open
282.31
Bid (Size)
265.00 (1)
Ask (Size)
300.00 (1)
Prev. Close
283.88
Today's Range
279.75 - 284.39
52wk Range
261.59 - 431.79
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via
AB Newswire
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Chronic conditions such as organ transplant rejection and cancer represent significant challenges in modern healthcare, demanding precise diagnostic tools for effective management and treatment. For...
Via
TheNewswire.com
Performance
YTD
-14.56%
-14.56%
1 Month
-2.04%
-2.04%
3 Month
-17.70%
-17.70%
6 Month
-12.68%
-12.68%
1 Year
-23.33%
-23.33%
More News
Read More
Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group
May 30, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference
May 23, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
The Analyst Landscape: 4 Takes On Bio-Rad Laboratories
May 08, 2024
Via
Benzinga
Bio-Rad Laboratories: Q4 Earnings Insights
February 15, 2024
Via
Benzinga
BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Bio-Rad Reports First-Quarter 2024 Financial Results
May 07, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
May 01, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Announces Life Science Group Management Changes
April 26, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Earnings Scheduled For February 15, 2024
February 15, 2024
Via
Benzinga
Preview: Bio-Rad Laboratories's Earnings
February 14, 2024
Via
Benzinga
96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?
April 18, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
April 18, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
April 10, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
March 20, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
February 22, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Tech Stocks Ease On Hot PPI, Yields Rise, Microsoft, Amazon Snap 5-Week Positive Streak: What's Driving Markets Friday?
February 16, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
February 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
February 15, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
January 24, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
10 S&P 500 Stocks With Over 40% Upside Potential: Hidden Gems Or Value Traps?
January 23, 2024
Via
Benzinga
Topics
Artificial Intelligence
Economy
Stocks
Exposures
Artificial Intelligence
Interest Rates
US Equities
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
January 02, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
December 07, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations
November 24, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
